Top Biotechnology Startups in Switzerland (2025 Update)
Explore the best Biotechnology companies in Switzerland. Discover high-growth startups and investment opportunities in our 2025 updated list.
👋🏼 Hey there! Bounce Watch here — I'm gathering key information from Top Biotechnology Startups in Switzerland list.
Real-Time Scouting Assistant

Explore Top Biotechnology Startups in Switzerland featuring 255 Companies
|
![]() |
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MetrioPharm | - | At the Forefront of Macrophage Metabolic Modulation | MetrioPharm AG is a Swiss biotech company developing first-in-class auto-regulat... | - |
|
Zurich | Switzerland (HQ) + 1 | 2007 | Biotechnology, Health Care +1 | - |
1
Low
|
20
|
180 (-100%) | 2 years ago | Grant | 2 | 20.3M | 910 | 8 months ago | ||
|
CorFlow Therapeutics | - | CorFlow Therapeutics creates a device for real-time MVO diagnosis and treatment... | CorFlow Therapeutics is a startup in the medical technology industry that is wor... | - |
|
Baar | Switzerland (HQ) | 2016 | Biotechnology | - |
1
Low
|
8
|
705 | - | Series A | - | 16.7M | 3868 | 7 qPf oim | ||
|
Histide | - | Histide uses non-mutagenic CRMs to stimulate a cell's natural capacity to redire... | Histide™ is pioneering Recoding Therapeutics™, a novel therapy using non-mutagen... | - |
|
Feusisberg | Switzerland (HQ) + 1 | 2014 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
8
|
118 (-80%) | 10 years ago | Series A | 1 | 4.5M | 1212 | 7 Hgi ifR | ||
|
Comphya | - | Providing a better solution for non-responders to oral drugs. | Comphya is a Swiss medical device company, spin-off from the Swiss Federal Insti... | - |
|
Ecublens | Switzerland (HQ) | 2017 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
8
|
1.2K | 2 years ago | Convertible Note | 6 | 5.4M | 918 | 5 months ago | ||
|
Scailyte | - | True precision medicine through single-cell science. |
True precision medicine through single-cell science. Scailyte, a pioneer in AI... |
- |
|
Basel | Switzerland (HQ) + 1 | 2017 | AI, Biotechnology +1 | [email protected] |
1
Low
|
23
|
869 (-49%) | 1 year ago | Series A | 9 | 15.5M | 5495 | 5 months ago | ||
|
TOLREMO therapeutics | - | Stopping non-genetic cancer drug resistance as it emerges | TOLREMO therapeutics' mission is to prevent non-genetic cancer drug resistance b... | - |
|
Basel | Switzerland (HQ) | 2017 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
14
|
988 (-100%) | 1 year ago | Series A | 4 | 19.5M | 5046 | 5 months ago | ||
|
NovaGo Therapeutics | - | NovaGo Therapeutics is a development stage biotech company focused on human anti... | NovaGo’s fully human monoclonal antibodies have the potential to become a safe a... | - |
|
Schlieren | Switzerland (HQ) | 2015 | Biotechnology, Health and Wellness | [email protected] |
1
Low
|
10
|
916 (262%) | 6 years ago | Series A | 1 | 10.0M | 678 | 5 months ago | ||
|
Pharvaris | - | Pioneering science for patient choice | Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-rec... | - |
|
Zug | Switzerland (HQ) + 2 | 2015 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
116
|
2.8K (-35%) | 1 year ago | Post Ipo Equity | 5 | 532.3M | 7077 | 5 months ago | ||
|
Aspivix | - | Together, Re-imagining Gynecology with "Gentle" in Mind. | Aspivix is a medical device company in women’s health, based in Switzerland, dev... | - |
|
Epalinges | Switzerland (HQ) | 2015 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
15
|
3.6K (-12%) | 11 months ago | Debt Financing | 14 | 13.1M | 5327 | 6 months ago | ||
|
Karmagenes SA | - | Business-to-Business customized genetic and psychometric data insights. #behavio... |
Our journey at a glance Karmagenes™ DNA-based Personality Test and Meet Yoursel... |
- |
|
Monthey | Switzerland (HQ) | 2015 | Analytics, Biotechnology +2 | [email protected] |
1
Low
|
2
|
664 | 9 years ago | Seed | 2 | 260.0K | 287 | 9 years ago | ||
|
Onena Medicines | - | AI-centric preclinical company discovering and developing novel biopharmaceutica... | Onena Medicines is a biopharmaceutical company with a pipeline of first-in-class... | - |
|
Basel | Switzerland (HQ) + 1 | 2019 | Biotechnology, Health Care +1 | - |
1
Low
|
13
|
1.4K (134%) | 1 year ago | Series Unknown | 4 | 6.4M | 1225 | 7 months ago | ||
|
Microcaps | - | Breakthrough technology to naturally encapsulate ingredients and fragrances into... |
We brings precise microencapsulation at industrial scale: Microcaps developed... |
- |
|
Schlieren | Switzerland (HQ) | 2019 | Biotechnology, IT +1 | - |
1
Low
|
31
|
887 (-100%) | 11 months ago | Series A | 6 | 14.4M | 3673 | 5 months ago | ||
|
Nagi Bioscience | - | in vivo testing at the in vitro scale | Nagi Bioscience is a pioneering high-tech startup developing NextGen laboratory... | - |
|
Lausanne | Switzerland (HQ) | 2019 | Biotechnology | [email protected] |
1
Low
|
33
|
1.6K | 1 year ago | Series A | 7 | 18.3M | 3435 | 8 months ago | ||
|
AgroSustain SA | - | AgroSustain – a one-stop-shop solution for biological plant protection. | AgroSustain – a one-stop-shop solution for biological plant protection. We aim t... | - |
|
Renens | Switzerland (HQ) | 2018 | Biotechnology, Food and Beverage +1 | https://www.agrosustain.ch/contact |
1
Low
|
9
|
17 | 4 years ago | Grant | 8 | 12.7M | 3735 | 5 months ago | ||
|
HemostOD | - | Inspired by platelet biology to save lives. | We engineer and manufacture platelets. | - |
|
Lausanne | Switzerland (HQ) | 2020 | Biotechnology, Manufacturing | - |
1
Low
|
8
|
29 (-94%) | 11 months ago | Debt Financing | 2 | 2.2M | 1154 | 6 months ago | ||
|
Adaptyv Bio | - | Next-generation protein engineering | Proteins are the most advanced nanotechnology we know of. At Adaptyv Bio we’re b... | - |
|
Lausanne | Switzerland (HQ) | 2020 | Biotechnology, Information Technology +1 | - |
1
Low
|
17
|
15.6K (140%) | 2 years ago | Debt Financing | 3 | 2.9M | 5944 | 5 months ago | ||
|
Alithea Genomics | - | Large scale RNA sequencing. Made easy. | RNA sequencing at scale. | - |
|
Lausanne | Switzerland (HQ) | 2020 | Biopharma, Biotechnology | - |
1
Low
|
28
|
753 (-100%) | 1 year ago | Seed | 6 | 6.0M | 3733 | 5 months ago | ||
|
VectivBio | - | Biotech company develops treatments for severe rare diseases, aims to become glo... | Our company is a clinical-stage biotech enterprise with a worldwide reach, dedic... | - |
|
Basel | Switzerland (HQ) | 2019 | Biotechnology, Health Care | [email protected] |
1
Low
|
57
|
881 | 2 years ago | Post Ipo Equity | 5 | 399.0M | 4330 | 1 year ago | ||
|
Alentis Therapeutics | - | We develop breakthrough treatments for Claudin1-positive tumors and organ fibros... | Alentis Therapeutics, the Claudin-1 (CLDN1) company, is a clinical stage biotech... | - |
|
Allschwil | Switzerland (HQ) | 2019 | Biotechnology, Health and Wellness | - |
1
Low
|
65
|
2.2K (29%) | 2 years ago | Grant | 4 | 184.0M | 9277 | 5 months ago | ||
|
Matterhorn Biosciences | - | M-TCR cell therapies targeting a new hallmark of cancer | Matterhorn is a leader in developing a new class of MR1 directed cell therapy ta... | - |
|
Basel | Switzerland (HQ) | 2020 | Biopharma, Biotechnology +1 | - |
1
Low
|
7
|
312 | 4 years ago | Series Unknown | 1 | 30.0M | 65338 | 6 tCX YXw | ||
|
Arvelle Therapeutics | - | A biopharmaceutical company committed to delivering groundbreaking solutions for... | Arvelle Therapeutics aims to provide cutting-edge treatments to patients who are... | - |
|
Basel | Switzerland (HQ) | 2019 | Biotechnology | [email protected] |
1
Low
|
964
|
905 | 5 years ago | Series A | 2 | 221.8M | 6305 | 1 year ago | ||
|
Rocketvax AG | - | Implementing cutting-edge science in next-generation vaccine design that will im... | The company brings together both scientific and operational expertise from vario... | - |
|
Basel | Switzerland (HQ) | 2020 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
6
|
618 | 3 years ago | Grant | 3 | 5.2M | 871 | 5 months ago | ||
|
Quercis Pharma | - | For a Healthier World | Quercis Pharma AG is leveraging its novel antithrombotic platform to deliver saf... | - |
|
Zug | Switzerland (HQ) | 2019 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
4
|
668 (374%) | 3 years ago | Private Equity | 1 | 150.0M | 54537 | 8 F5b wuc | ||
|
MaxWell Biosystems | - | Every Cell Has A Story To Tell. Connect to your cells and track their activity,... | Founded in September 2016 as an ETH ZĂĽrich spin-off, MaxWell Biosystems is a tec... | - |
|
Zurich | Switzerland (HQ) | 2016 | Biotechnology, Health Care | [email protected] |
1
Low
|
52
|
6.8K (-3%) | 3 years ago | Debt Financing | 6 | 4.7M | 6388 | 5 months ago | ||
|
GliaPharm SA | - | Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases | GliaPharm is a Swiss-based biotechnology company that develops treatments for ne... | - |
|
Geneva | Switzerland (HQ) | 2016 | Biotechnology, Health Care | [email protected] |
1
Low
|
11
|
913 (-17%) | 1 year ago | Grant | 4 | 6.4M | 1507 | 6 months ago | ||
|
Lunaphore (a Bio-Techne b... | - | Accelerating Spatial Biology. | Lunaphore Technologies S.A., a Bio-Techne brand, is a Swiss-based life sciences... | - |
|
Lausanne | Switzerland (HQ) | 2014 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
159
|
496 (-100%) | 2 years ago | Series D | 15 | 94.4M | 22644 | 6 months ago | ||
|
Noema Pharma | - | Developing therapies to restore functioning in patients with orphan conditions o... | Noema Pharma is a biotech company developing groundbreaking therapies to address... | - |
|
Basel | Switzerland (HQ) | 2019 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
32
|
3.1K | 2 years ago | Series B | 2 | 157.0M | 4301 | 5 months ago | ||
|
CHORD Therapeutics | - | Chord Therapeutics is dedicated to bringing new treatments to patients affected... | Chord Therapeutics is a clinical-stage pharmaceutical company developing drugs f... | - |
|
Geneva | Switzerland (HQ) | 2014 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
16
|
20 | 4 years ago | Series A | 2 | 16.0M | 72473 | 3 BGC nS1 | ||
|
Cellestia Biotech | - | Cellestia develops targeted therapies for cancer patients with no other options,... | Cellestia Biotech is pioneering innovative therapeutics based on novel modes of... | - |
|
Basel | Switzerland (HQ) + 1 | 2014 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
15
|
244 (-66%) | 1 year ago | Non Equity Assistance | 10 | 48.7M | 5671 | 11 months ago | ||
|
REM Analytics | - | REM Analytics measures the microtype of people for the microbiome industry to im... | The microbiome is the ecosystem of micro-organisms that live in and around us, m... | - |
|
Lausanne | Switzerland (HQ) | 2019 | Analytics, Biotechnology | - |
1
Low
|
6
|
565 (-100%) | 7 years ago | Grant | 2 | 110.0K | 604 | 5 months ago | ||
|
hemotune AG | - | We are a Swiss company on a mission to combat sepsis through magnetic blood puri... | We are a start-up medical device company originating from ETH Zurich and are pas... | - |
|
Schlieren | Switzerland (HQ) | 2017 | Biotechnology, Health Care +3 | [email protected] |
1
Low
|
25
|
680 | 1 year ago | Series B | 14 | 33.8M | 3437 | 5 months ago | ||
|
Testmate Health | - | Sex is fun. Testmate makes it safe. | Testmate Health is a an early stage healthcare startup focused on low cost, high... | - |
|
Lausanne | Switzerland (HQ) | 2020 | Biotechnology, Health Care +3 | [email protected] |
1
Low
|
13
|
243 | 1 year ago | Seed | 9 | 8.8M | 3081 | 6 months ago | ||
|
AlveoliX | - | In-vitro models inspired by nature Ι Organs-on-Chip |
Our Vision We aim at changing the way drug development research is done today by... |
- |
|
Bern | Switzerland (HQ) | 2019 | Biotechnology, Life Sciences | [email protected] |
1
Low
|
11
|
1.9K | 6 years ago | Grant | 3 | 30.0K | 5218 | 5 months ago | ||
|
MIRAI FOODS | - | We are developing real meat - cultivated directly from animal cells in Switzerla... |
We are developing real meat - cultivated directly from animal cells ! Our missi... |
- |
|
Wadenswil | Switzerland (HQ) | 2019 | Biotechnology, Food and Beverage | - |
1
Low
|
5
|
96 (-86%) | 4 years ago | Seed | 2 | 6.9M | 5467 | 2 years ago | ||
|
Qnami | - | Unlocking quantum technology to enable a better world. | At Qnami we develop fundamental new technology using quantum mechanics. The cont... | - |
|
Muttenz | Switzerland (HQ) | 2017 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
19
|
3.1K (-14%) | 3 years ago | Grant | 8 | 7.3M | 5030 | 2 years ago | ||
|
Novigenix SA | - | Leader in Immuno-Transcriptomic Precision Medicine solutions | Novigenix is a Swiss precision medicine company specialized in ImmunoTranscripto... | - |
|
Lausanne | Switzerland (HQ) + 1 | 2014 | AI, Analytics +4 | [email protected] |
1
Low
|
26
|
418 (-18%) | 2 years ago | Series B | 2 | 21.1M | 2749 | 5 months ago | ||
|
Oculis | - | Oculis develops eye drops to treat ophthalmic diseases, improving patients' live... | Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposeful... | - |
|
Lausanne | Switzerland (HQ) + 2 | 2017 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
54
|
3.1K | 1 year ago | Post Ipo Equity | 13 | 384.6M | 4448 | 3 months ago | ||
|
FimmCyte | - | First disease modifying treatment for Endometriosis. | First disease modifying treatment for Endometriosis | - |
|
Basel | Switzerland (HQ) | 2022 | Biotechnology, Health Care | [email protected] |
1
Low
|
5
|
404 (-17%) | 1 year ago | Convertible Note | 7 | 5.0M | 4046 | 6 months ago | ||
|
GlycoEra AG | - | Advancing Glycan Mediated Therapy | GlycoEra is positioned as the leading precision protein degradation company. Bif... | - |
|
Wadenswil | Switzerland (HQ) | 2020 | Biotechnology, Health Care | [email protected] |
1
Low
|
34
|
603 | 1 year ago | Series A | 2 | 45.0M | 3400 | 6 months ago | ||
|
Bright Peak Therapeutics | - | Better Biologics Through Chemistry | Bright Peak are developing a portfolio of first-in-class and best-in-class cytok... | - |
|
Basel | Switzerland (HQ) + 1 | 2017 | Biotechnology, Health and Wellness +1 | - |
1
Low
|
56
|
2.1K | 11 months ago | Series C | 3 | 232.0M | 6677 | 4 months ago |